291 related articles for article (PubMed ID: 1524898)
1. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
van Dongen JA; Bartelink H; Fentiman IS; Lerut T; Mignolet F; Olthuis G; van der Schueren E; Sylvester R; Tong D; Winter J
Eur J Cancer; 1992; 28A(4-5):801-5. PubMed ID: 1524898
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.
van Dongen JA; Bartelink H; Fentiman IS; Lerut T; Mignolet F; Olthuis G; van der Schueren E; Sylvester R; Winter J; van Zijl K
J Natl Cancer Inst Monogr; 1992; (11):15-8. PubMed ID: 1627421
[TBL] [Abstract][Full Text] [Related]
3. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
Litière S; Werutsky G; Fentiman IS; Rutgers E; Christiaens MR; Van Limbergen E; Baaijens MH; Bogaerts J; Bartelink H
Lancet Oncol; 2012 Apr; 13(4):412-9. PubMed ID: 22373563
[TBL] [Abstract][Full Text] [Related]
4. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
van Dongen JA; Voogd AC; Fentiman IS; Legrand C; Sylvester RJ; Tong D; van der Schueren E; Helle PA; van Zijl K; Bartelink H
J Natl Cancer Inst; 2000 Jul; 92(14):1143-50. PubMed ID: 10904087
[TBL] [Abstract][Full Text] [Related]
6. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
van Tienhoven G; Voogd AC; Peterse JL; Nielsen M; Andersen KW; Mignolet F; Sylvester R; Fentiman IS; van der Schueren E; van Zijl K; Blichert-Toft M; Bartelink H; van Dongen JA
Eur J Cancer; 1999 Jan; 35(1):32-8. PubMed ID: 10211085
[TBL] [Abstract][Full Text] [Related]
7. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
8. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
Bartelink H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Borger J; Jager J; Hoogenraad W; Collette L; Pierart M;
N Engl J Med; 2001 Nov; 345(19):1378-87. PubMed ID: 11794170
[TBL] [Abstract][Full Text] [Related]
9. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
10. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
11. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
[TBL] [Abstract][Full Text] [Related]
12. Early-stage bilateral breast cancer treated with breast-conserving surgery and definitive irradiation: the University of Pennsylvania experience.
Fung MC; Schultz DJ; Solin LJ
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):959-67. PubMed ID: 9276360
[TBL] [Abstract][Full Text] [Related]
13. Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy.
Cajucom CC; Tsangaris TN; Nemoto T; Driscoll D; Penetrante RB; Holyoke ED
Cancer; 1993 Mar; 71(5):1774-9. PubMed ID: 8448741
[TBL] [Abstract][Full Text] [Related]
14. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
15. Local recurrence after breast-conserving surgery and radiotherapy.
Kurtz JM; Amalric R; Brandone H; Ayme Y; Spitalier JM
Helv Chir Acta; 1989 Apr; 55(6):837-42. PubMed ID: 2753724
[TBL] [Abstract][Full Text] [Related]
16. Local recurrence risk after previous salvage mastectomy.
Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
[TBL] [Abstract][Full Text] [Related]
17. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
18. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
Poggi MM; Danforth DN; Sciuto LC; Smith SL; Steinberg SM; Liewehr DJ; Menard C; Lippman ME; Lichter AS; Altemus RM
Cancer; 2003 Aug; 98(4):697-702. PubMed ID: 12910512
[TBL] [Abstract][Full Text] [Related]
19. Microscopic residual disease is a risk factor in the primary treatment of breast cancer.
Schuck A; Könemann S; Heinen K; Rübe CE; Hesselmann S; Reinartz G; Schüller P; Micke O; Schäfer U; Willich N
Strahlenther Onkol; 2002 Jun; 178(6):307-13. PubMed ID: 12122786
[TBL] [Abstract][Full Text] [Related]
20. Salvage mastectomy for local and regional recurrence after breast-conserving operation and radiation therapy.
Osborne MP; Borgen PI; Wong GY; Rosen PP; McCormick B
Surg Gynecol Obstet; 1992 Mar; 174(3):189-94. PubMed ID: 1542833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
